WAM
INFI

Wolverine Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Wolverine Asset Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-23,600
Closed -$317K – 2845
2013
Q4 		$325K Buy
+23,600
New +$333K 0.01% 940

Other funds holding INFI

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolverine Asset Management's INFI Position: Q1 2014 in Review

Wolverine Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q1 2014, closing a stake of 23,600 shares — an estimated $317K sold.

Wolverine Asset Management first reported a position in INFI in Q4 2013 and held it in 1 quarter. The position peaked at $325K in Q4 2013. 98 funds tracked by Wall St. Rank hold INFI as of Q1 2014.

  • Wolverine Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q1 2014 after selling out during the quarter.
  • Wolverine Asset Management sold 23,600 Infinity Pharmaceuticals, Inc. shares in Q1 2014, an estimated $317K.
  • Wolverine Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2013 and held it in 1 quarter.
  • Wolverine Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $325K in Q4 2013.
  • 98 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q1 2014.

Based on Wolverine Asset Management's 13F filing for Q1 2014, filed 14 May 2014.